Assessment of bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with asthma

Siegfried Bauer, Ha Neul Park, Hyun Suk Seo, Ji Eun Kim, Dae-Jin Song, Sang Hee Park, Ji-Tae Choung, Young Yoo, Hyung Jin Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this study was to investigate bronchodilator responsiveness (BDR) following methacholine-induced bronchoconstriction and to determine differences in BDR according to clinical parameters in children with asthma. Methods: The methacholine challenge test was performed in 145 children with mild to moderate asthma, and the provocative concentration causing a 20% decline in FEV1 (PC20) was determined. Immediately after the challenge test, patients were asked to inhale short-acting β2-agonists (SABAs) to achieve BDR, which was assessed as the change in FEV1% predicted×100/post-methacholine FEV1% predicted. For each subject, the asthma medication, blood eosinophil count, serum total IgE, serum eosinophil cationic protein level, and skin prick test result were assessed. Results: The FEV1 (mean±SD) values of the 145 patients were 90.5±10.9% predicted, 64.2±11.5% predicted, and 86.2±11.2% predicted before and after methacholine inhalation, and following the administration of a SABA, respectively. The BDR did not differ significantly according to asthma medication, age, or gender. However, BDR in the atopy group (37.4±17.7%) was significantly higher than that in the non-atopy group (30.5±10.7%; P=0.037). Patients with blood eosinophilia (38.6± 18.1%) displayed increased BDR compared with patients without eosinophilia (32.0±13.8%; P=0.037). Conclusions: In children with mild to moderate asthma, the responsiveness to short-acting bronchodilators after methacholine-induced bronchoconstriction was not related to asthma medication, but was higher in children with atopy and/or peripheral blood eosinophilia.

Original languageEnglish
Pages (from-to)245-250
Number of pages6
JournalAllergy, Asthma and Immunology Research
Volume3
Issue number4
DOIs
Publication statusPublished - 2011 Oct 1

Fingerprint

Bronchoconstriction
Methacholine Chloride
Bronchodilator Agents
Asthma
Eosinophilia
Inhalation Administration
Eosinophil Cationic Protein
Skin Tests
Eosinophils
Immunoglobulin E
Serum

Keywords

  • Asthma
  • Atopy
  • Beta-adrenergic agonist
  • Child
  • Eosinophilia
  • Methacholine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

Assessment of bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with asthma. / Bauer, Siegfried; Park, Ha Neul; Seo, Hyun Suk; Kim, Ji Eun; Song, Dae-Jin; Park, Sang Hee; Choung, Ji-Tae; Yoo, Young; Kim, Hyung Jin.

In: Allergy, Asthma and Immunology Research, Vol. 3, No. 4, 01.10.2011, p. 245-250.

Research output: Contribution to journalArticle

Bauer, Siegfried ; Park, Ha Neul ; Seo, Hyun Suk ; Kim, Ji Eun ; Song, Dae-Jin ; Park, Sang Hee ; Choung, Ji-Tae ; Yoo, Young ; Kim, Hyung Jin. / Assessment of bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with asthma. In: Allergy, Asthma and Immunology Research. 2011 ; Vol. 3, No. 4. pp. 245-250.
@article{6c1b4968929a4a97ae55faf65662d1e0,
title = "Assessment of bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with asthma",
abstract = "The aim of this study was to investigate bronchodilator responsiveness (BDR) following methacholine-induced bronchoconstriction and to determine differences in BDR according to clinical parameters in children with asthma. Methods: The methacholine challenge test was performed in 145 children with mild to moderate asthma, and the provocative concentration causing a 20{\%} decline in FEV1 (PC20) was determined. Immediately after the challenge test, patients were asked to inhale short-acting β2-agonists (SABAs) to achieve BDR, which was assessed as the change in FEV1{\%} predicted×100/post-methacholine FEV1{\%} predicted. For each subject, the asthma medication, blood eosinophil count, serum total IgE, serum eosinophil cationic protein level, and skin prick test result were assessed. Results: The FEV1 (mean±SD) values of the 145 patients were 90.5±10.9{\%} predicted, 64.2±11.5{\%} predicted, and 86.2±11.2{\%} predicted before and after methacholine inhalation, and following the administration of a SABA, respectively. The BDR did not differ significantly according to asthma medication, age, or gender. However, BDR in the atopy group (37.4±17.7{\%}) was significantly higher than that in the non-atopy group (30.5±10.7{\%}; P=0.037). Patients with blood eosinophilia (38.6± 18.1{\%}) displayed increased BDR compared with patients without eosinophilia (32.0±13.8{\%}; P=0.037). Conclusions: In children with mild to moderate asthma, the responsiveness to short-acting bronchodilators after methacholine-induced bronchoconstriction was not related to asthma medication, but was higher in children with atopy and/or peripheral blood eosinophilia.",
keywords = "Asthma, Atopy, Beta-adrenergic agonist, Child, Eosinophilia, Methacholine",
author = "Siegfried Bauer and Park, {Ha Neul} and Seo, {Hyun Suk} and Kim, {Ji Eun} and Dae-Jin Song and Park, {Sang Hee} and Ji-Tae Choung and Young Yoo and Kim, {Hyung Jin}",
year = "2011",
month = "10",
day = "1",
doi = "10.4168/aair.2011.3.4.245",
language = "English",
volume = "3",
pages = "245--250",
journal = "Allergy, Asthma and Immunology Research",
issn = "2092-7355",
publisher = "Korean Academy of Asthma, Allergy and Clinical Immunology",
number = "4",

}

TY - JOUR

T1 - Assessment of bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with asthma

AU - Bauer, Siegfried

AU - Park, Ha Neul

AU - Seo, Hyun Suk

AU - Kim, Ji Eun

AU - Song, Dae-Jin

AU - Park, Sang Hee

AU - Choung, Ji-Tae

AU - Yoo, Young

AU - Kim, Hyung Jin

PY - 2011/10/1

Y1 - 2011/10/1

N2 - The aim of this study was to investigate bronchodilator responsiveness (BDR) following methacholine-induced bronchoconstriction and to determine differences in BDR according to clinical parameters in children with asthma. Methods: The methacholine challenge test was performed in 145 children with mild to moderate asthma, and the provocative concentration causing a 20% decline in FEV1 (PC20) was determined. Immediately after the challenge test, patients were asked to inhale short-acting β2-agonists (SABAs) to achieve BDR, which was assessed as the change in FEV1% predicted×100/post-methacholine FEV1% predicted. For each subject, the asthma medication, blood eosinophil count, serum total IgE, serum eosinophil cationic protein level, and skin prick test result were assessed. Results: The FEV1 (mean±SD) values of the 145 patients were 90.5±10.9% predicted, 64.2±11.5% predicted, and 86.2±11.2% predicted before and after methacholine inhalation, and following the administration of a SABA, respectively. The BDR did not differ significantly according to asthma medication, age, or gender. However, BDR in the atopy group (37.4±17.7%) was significantly higher than that in the non-atopy group (30.5±10.7%; P=0.037). Patients with blood eosinophilia (38.6± 18.1%) displayed increased BDR compared with patients without eosinophilia (32.0±13.8%; P=0.037). Conclusions: In children with mild to moderate asthma, the responsiveness to short-acting bronchodilators after methacholine-induced bronchoconstriction was not related to asthma medication, but was higher in children with atopy and/or peripheral blood eosinophilia.

AB - The aim of this study was to investigate bronchodilator responsiveness (BDR) following methacholine-induced bronchoconstriction and to determine differences in BDR according to clinical parameters in children with asthma. Methods: The methacholine challenge test was performed in 145 children with mild to moderate asthma, and the provocative concentration causing a 20% decline in FEV1 (PC20) was determined. Immediately after the challenge test, patients were asked to inhale short-acting β2-agonists (SABAs) to achieve BDR, which was assessed as the change in FEV1% predicted×100/post-methacholine FEV1% predicted. For each subject, the asthma medication, blood eosinophil count, serum total IgE, serum eosinophil cationic protein level, and skin prick test result were assessed. Results: The FEV1 (mean±SD) values of the 145 patients were 90.5±10.9% predicted, 64.2±11.5% predicted, and 86.2±11.2% predicted before and after methacholine inhalation, and following the administration of a SABA, respectively. The BDR did not differ significantly according to asthma medication, age, or gender. However, BDR in the atopy group (37.4±17.7%) was significantly higher than that in the non-atopy group (30.5±10.7%; P=0.037). Patients with blood eosinophilia (38.6± 18.1%) displayed increased BDR compared with patients without eosinophilia (32.0±13.8%; P=0.037). Conclusions: In children with mild to moderate asthma, the responsiveness to short-acting bronchodilators after methacholine-induced bronchoconstriction was not related to asthma medication, but was higher in children with atopy and/or peripheral blood eosinophilia.

KW - Asthma

KW - Atopy

KW - Beta-adrenergic agonist

KW - Child

KW - Eosinophilia

KW - Methacholine

UR - http://www.scopus.com/inward/record.url?scp=83655193282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655193282&partnerID=8YFLogxK

U2 - 10.4168/aair.2011.3.4.245

DO - 10.4168/aair.2011.3.4.245

M3 - Article

VL - 3

SP - 245

EP - 250

JO - Allergy, Asthma and Immunology Research

JF - Allergy, Asthma and Immunology Research

SN - 2092-7355

IS - 4

ER -